ATOH1 and neoplasm: Previous studies showed that 70% of colorectal cancer patient samples have significantly decreased expression of ATOH1 compared to tissue-matched normal LI samples, and revealed ATOH1 as a tumor suppressor in vitro and in vivo [48].